ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes
暂无分享,去创建一个
Kenneth Offit | David G. Mutch | Stephen Gruber | Barbara L. Weber | Monica Morrow | William C. Wood | James Church | S. Gruber | B. Karlan | A. Berchuck | B. Weber | K. Offit | J. Church | D. Mutch | M. Morrow | J. Guillem | W. Wood | J. Moley | J. Weitzel | F. Giardiello | José G. Guillem | Jeffrey F. Moley | Andrew Berchuck | Beth Y. Karlan | Robert F. Gagel | Jeffrey Weitzel | Francis Giardiello | Miguel A. Rodriguez-Bigas | M. Rodriguez-Bigas | R. Gagel
[1] H. Vasen,et al. Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis in familial adenomatous polyposis. , 1999, Annals of surgery.
[2] L. Aaltonen,et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. , 2000, Gastroenterology.
[3] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[4] F. Nagengast,et al. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) , 1995, The Lancet.
[5] J. Church,et al. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis , 1992, Diseases of the colon and rectum.
[6] J. Church. Mucosal ischemia caused by desmoid tumors in patients with familial adenomatous polyposis , 1998, Diseases of the colon and rectum.
[7] D. Marsh,et al. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. , 1997, Archives of surgery.
[8] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[9] B. Rosen,et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.
[10] H. Osmond-Clarke. Recurrent dislocation of the shoulder. , 1947, Lancet.
[11] R. Kryscio,et al. Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. , 2002, Gynecologic oncology.
[12] J. Church,et al. IIeal Pouch‐Anal Anastomoses Complications and Function in 1005 Patients , 1995, Annals of surgery.
[13] L. Mulligan,et al. Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease , 1997, Human mutation.
[14] J. Ivanovich,et al. Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A , 1994, Annals of surgery.
[15] A. Spigelman,et al. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis , 1993, Diseases of the colon and rectum.
[16] N. Petrelli,et al. Rectal cancer in hereditary nonpolyposis colorectal cancer. , 2001, American journal of surgery.
[17] R. Fitzgibbons,et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). , 1987, Annals of surgery.
[18] E. Buskens,et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. , 1997, Gut.
[19] C. Kuhl,et al. Surveillance of "high risk" women with proven or suspected familial (hereditary) breast cancer: First mid-term results of a multi-modality clinical screening trial , 2003 .
[20] T. Rebbeck,et al. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. , 1998, American journal of obstetrics and gynecology.
[21] B. Pasini,et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.
[22] D. Tyler,et al. Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis , 2002, Journal of Gastrointestinal Surgery.
[23] J. Guillem,et al. Gastrointestinal polyposis syndromes. , 1999, Current problems in surgery.
[24] Siân Jones,et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH , 2003, The Lancet.
[25] E. Thomson,et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. , 1997, JAMA.
[26] A D Carothers,et al. Cancer risk associated with germline DNA mismatch repair gene mutations. , 1997, Human molecular genetics.
[27] W. Bemelman,et al. Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature. , 1999, European journal of gastroenterology & hepatology.
[28] H C van Houwelingen,et al. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.
[29] S. Miller,et al. Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer. , 1986, Surgery.
[30] H. Lynch. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? , 1996, Diseases of the colon and rectum.
[31] L. Aaltonen,et al. Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome , 1995, International journal of cancer.
[32] B. Grube,et al. MRI of occult breast carcinoma in a high-risk population , 2004 .
[33] J. Church,et al. Incidence of neoplastic polyps in the ileal pouch of patients with familial adenomatous polyposis after restorative proctocolectomy , 1998, Diseases of the colon and rectum.
[34] K. T. Chen,et al. Peritoneal Carcinomatosis After Prophylactic Oophorectomy in Familial Ovarian Cancer Syndrome , 1985, Obstetrics and gynecology.
[35] J. Guillem,et al. Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery , 2002, Journal of Gastrointestinal Surgery.
[36] D Lowe,et al. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. , 1999, Journal of the National Cancer Institute.
[37] Z. Cohen,et al. Management of advanced duodenal polyposis in familial adenomatous polyposis , 1997, Journal of Gastrointestinal Surgery.
[38] J. Niloff,et al. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] P. Tonin,et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results , 1997, Cancer.
[40] F. Giardiello,et al. Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. , 2001, Gastroenterology.
[41] P. Goodfellow,et al. Mutational analysis of MLH1 and MSH2 in 25 prospectively‐acquired RER+ endometrial cancers , 1997, Genes, chromosomes & cancer.
[42] S. Skapek,et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] A. Godwin,et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. , 1996, Journal of the National Cancer Institute.
[44] J. Kleibeuker,et al. Surveillance for Hereditary Nonpolyposis Colorectal Cancer , 2002 .
[45] T. Rebbeck,et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. , 2002, Journal of the National Cancer Institute.
[46] G. Beck,et al. Colectomy with ileorectal anastomosis for familial adenomatous polyposis: the risk of rectal cancer. , 1987, Surgery.
[47] P. Casali,et al. Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis , 2001, Cancer.
[48] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[49] B. Ponder,et al. Prophylactic oophorectomy in inherited breast/ovarian cancer families. , 1995, Journal of the National Cancer Institute. Monographs.
[50] H T Lynch,et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.
[51] A. Cats,et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect , 2003, Gut.
[52] W. Gerald,et al. Value of Immunohistochemical Detection of DNA Mismatch Repair Proteins in Predicting Germline Mutation in Hereditary Colorectal Neoplasms , 2005, The American journal of surgical pathology.
[53] L. J. Schelven,et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group , 2004 .
[54] R. Broaddus,et al. Gynecologic Cancer as a “Sentinel Cancer” for Women With Hereditary Nonpolyposis Colorectal Cancer Syndrome , 2005, Obstetrics and gynecology.
[55] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[56] Bruce A.J. Ponder,et al. Oral Contraceptives and the Risk of Hereditary Ovarian Cancer , 1998 .
[57] K. Aittomäki,et al. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. , 2001, Gynecologic oncology.
[58] E. Thomson,et al. Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .
[59] A S Whittemore,et al. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.
[60] M. King,et al. Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.
[61] B. Ponder,et al. Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium , 1995, Journal of internal medicine.
[62] P. Radice,et al. Genotype and Phenotype Factors as Determinants for Rectal Stump Cancer in Patients With Familial Adenomatous Polyposis , 2000 .
[63] Torn,et al. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[64] G. Rennert,et al. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma. , 2004, Gynecologic oncology.
[65] J. Church,et al. Mucosectomy vs. stapled ileal pouch—anal anastomosis in patients with familial adenomatous polyposis: Functional outcome and neoplasia control , 2001, Diseases of the colon and rectum.
[66] Deborah Schrag,et al. Benefits of Colonoscopic Surveillance and Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer Mutations , 1998, Annals of Internal Medicine.
[67] O. Olopade,et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] D. Clayton,et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation , 1995, Nature Genetics.
[69] H. Nelson,et al. Quality of Life After Ileal Pouch-Anal Anastomosis and Ileorectal Anastomosis in Patients With Familial Adenomatous Polyposis , 2005, Diseases of the colon and rectum.
[70] D. Clayton,et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.
[71] S. Baylin,et al. Inherited medullary thyroid carcinoma: a final monoclonal mutation in one of multiple clones of susceptible cells. , 1978, Science.
[72] D. Easton,et al. Contribution of BRCA1 mutations to ovarian cancer. , 1997, The New England journal of medicine.
[73] K. Neale,et al. Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis , 1991, The British journal of surgery.
[74] H. Järvinen,et al. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment , 1996, International Journal of Colorectal Disease.
[75] A. Spigelman,et al. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. , 1996, Gastroenterology.
[76] H. Lynch,et al. Carcinoma of the breast and ovary in three families. , 1971, Surgery, gynecology & obstetrics.
[77] L. Lipton,et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. , 2003, The New England journal of medicine.
[78] A. de la Chapelle,et al. Hereditary Colorectal Cancer , 2010 .
[79] H. Hollema,et al. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] Z. Cohen,et al. Desmoid disease in patients with familial adenomatous polyposis , 2000, Diseases of the colon and rectum.
[81] B. Nordlinger,et al. Ileal pouch-anal anastomosis as the first choice operation in patients with familial adenomatous polyposis: a ten-year experience. , 1996, Surgery.
[82] M. Wood,et al. Risk of breast and ovarian cancer in women with strong family histories. , 2001, Oncology.
[83] P. Propping,et al. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. , 2001, Gastroenterology.
[84] S. Thibodeau,et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. , 1996, Cancer research.
[85] A H Tashjian,et al. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. , 1988, The New England journal of medicine.
[86] C. Boland,et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.
[87] R. Fitzgibbons,et al. Role of prophylactic colectomy in Lynch syndrome. , 2003, Clinical colorectal cancer.
[88] T. Lairmore,et al. Gastrointestinal Manifestations of Multiple Endocrine Neoplasia Type 2 , 2002, Annals of surgery.
[89] K. Offit,et al. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes , 2000, Cancer.
[90] M. Sivak,et al. Gastroduodenal polyps in patients with familial adenomatous polyposis , 1992, Diseases of the colon and rectum.
[91] J. Tjandra,et al. Transanal mucosectomy , 1994, Diseases of the colon and rectum.
[92] B. Nordlinger,et al. Operation and abdominal desmoid tumors in familial adenomatous polyposis. , 1993, Surgery, gynecology & obstetrics.
[93] J. Tobacman,et al. INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES , 1982, The Lancet.
[94] J. Disario,et al. Approaches to endoscopic ampullectomy , 2004, Current opinion in gastroenterology.
[95] R. Fishel,et al. Mismatch Repair and the Hereditary Non-polyposis Colorectal Cancer Syndrome (HNPCC) , 2002, Cancer investigation.
[96] E. Levy-Lahad,et al. BRCA1 Germline Mutations in Women With Uterine Serous Papillary Carcinoma , 2000, Obstetrics and gynecology.
[97] K. Offit,et al. Hereditary cancer predisposition syndromes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[98] B. Rosen,et al. A genetic epidemiological study of carcinoma of the fallopian tube. , 2001, Gynecologic oncology.
[99] M. Beattie,et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[100] Z. Cohen,et al. Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis , 2001, Diseases of the colon and rectum.
[101] Douglas F Easton,et al. Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.
[102] T. van Vroonhoven,et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. , 1994, The New England journal of medicine.
[103] T. Iwama,et al. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[104] J. Church,et al. Predicting polyposis severity by proctoscopy , 2001, Diseases of the colon and rectum.
[105] B. Ponder,et al. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. , 1998, The New England journal of medicine.
[106] L. Messerini,et al. Long‐term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer? , 2000, Journal of surgical oncology.
[107] J. Mecklin,et al. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. , 1994, The American journal of medicine.
[108] A. Gunn,et al. Morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis , 1991, The British journal of surgery.
[109] H. Lynch,et al. Rectal cancer after prolonged sulindac chemoprevention. A case report , 1995, Cancer.
[110] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[111] J. Church,et al. Attenuated Familial Adenomatous Polyposis , 2002, Diseases of the colon and rectum.
[112] M. Piver,et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the gilda radner familial ovarian cancer registry , 1993, Cancer.
[113] Z. Cohen,et al. Comparison of ileal pouch-anal anastomosis and ileorectal anastomosis in patients with familial adenomatous polyposis , 1999, Diseases of the colon and rectum.
[114] J. Mecklin,et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.
[115] Daniel J Sargent,et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[116] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[117] C. Rossetti,et al. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. , 1994, Seminars in surgical oncology.
[118] J. Klijn,et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.
[119] R. Hinze,et al. Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience , 1998, World Journal of Surgery.
[120] Mark E. Robson,et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation , 2002 .
[121] P. V. van Diest,et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. , 2000, Gynecologic oncology.
[122] B. Alford,et al. Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. , 1989, Annals of internal medicine.
[123] R. Fitzgibbons,et al. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome , 1994, Diseases of the colon and rectum.
[124] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[125] M. Swift,et al. Cancer predisposition of ataxia-telangiectasia heterozygotes. , 1990, Cancer genetics and cytogenetics.
[126] J. Church,et al. Patterns of Surgery in Patients Belonging to Amsterdam-Positive Families , 2003, Diseases of the colon and rectum.
[127] B. Levin,et al. A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis , 2002, Gut.
[128] W. Wood,et al. Skin-sparing mastectomy. Oncologic and reconstructive considerations. , 1997, Annals of surgery.
[129] S. Olschwang,et al. Familial Adenomatous Polyposis: Prevalence of Adenomas in the Ileal Pouch After Restorative Proctocolectomy , 2001, Annals of surgery.
[130] J. Fraumeni,et al. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? , 1969, Annals of internal medicine.
[131] J. Guillem,et al. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis , 1999, Journal of Gastrointestinal Surgery.
[132] P. Goodfellow,et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. , 1993, Human molecular genetics.
[133] J. Satagopan,et al. Risk of Endometrial Carcinoma Associated With BRCA Mutation , 2001 .
[134] J. Stockman. Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) , 2006 .
[135] J. Jass,et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. , 1997, Annals of surgery.
[136] L. Cannon-Albright,et al. Characterization of common BRCA1 and BRCA2 variants. , 2002, Genetic testing.
[137] S. Seal,et al. Brave new now , 2013, Nature Genetics.
[138] M. Ballegooijen,et al. A cost‐effectiveness analysis of colorectal screening for hereditary nonpolyposis colorectal carcinoma gene carriers , 1998, Cancer.
[139] H. Nelson,et al. [Rectal carcinomas in HNPCC]. , 1998, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress.
[140] J. Norton,et al. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. , 1996, Journal of pediatric surgery.
[141] G. Kenter,et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. , 2002, Cancer.
[142] J. Church. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. , 1996, Annals of medicine.
[143] M. Ewertz,et al. Breast cancer incidence subsequent to surgical reduction of the female breast. , 1988, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[144] R. Broaddus,et al. Unexpected Endometrial Cancer at Prophylactic Hysterectomy in a Woman With Hereditary Nonpolyposis Colon Cancer , 2003, Obstetrics and gynecology.
[145] I. Christensen,et al. Duodenal adenomatosis in familial adenomatous polyposis , 2004, Gut.
[146] F. Raue,et al. Application of genetic screening in families with hereditary medullary thyroid carcinoma* , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[147] Chen Kt,et al. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. , 1985 .
[148] J. Krischer,et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases , 2005, Cancer.
[149] W. Foulkes,et al. Familial Adenomatous Polyposis , 2006, The American Journal of Gastroenterology.
[150] J. Jass,et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. , 1994, Anticancer research.
[151] G. Petersen,et al. AGA technical review on hereditary colorectal cancer and genetic testing. , 2001, Gastroenterology.
[152] P. Radice,et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[153] J. Church,et al. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). , 2003, Diseases of the colon and rectum.
[154] A. Tischler,et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.
[155] P. Møller,et al. Familial endometrial cancer in female carriers of MSH6 germline mutations , 1999, Nature Genetics.
[156] W. Bodmer,et al. DNA mismatch repair genes and colorectal cancer , 2000, Gut.
[157] G. Lenoir,et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23 , 1991, The Lancet.
[158] H. Järvinen,et al. Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. , 1995, International journal of colorectal disease.
[159] T. Colgan,et al. Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy. , 2002, Gynecologic oncology.
[160] A. Russo,et al. Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry. , 2000, Annals of surgery.
[161] M. Goggins,et al. Prevention and management of duodenal polyps in familial adenomatous polyposis , 2005, Gut.
[162] R. Fodde,et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. , 1996, Gastroenterology.
[163] C. Tops,et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis , 1996, The Lancet.
[164] A. Tsaroucha,et al. Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. , 2001, Surgery.
[165] J. Mecklin,et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. , 2001, Gynecologic oncology.
[166] K. Offit,et al. Reducing the risk of gynecologic cancer in the Lynch syndrome. , 2006, The New England journal of medicine.
[167] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[168] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[169] N. Aaronson,et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[170] B. Levin. NCCN COLORECTAL CANCER SCREENING PRACTICE GUIDELINES , 1999 .
[171] G. Piazza,et al. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. , 1999, Advances in experimental medicine and biology.
[172] C. Eng,et al. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. , 1995, Surgery.
[173] R. A. Decker,et al. Prophylactic Surgery for Multiple Endocrine Neoplasia Type IIa after Genetic Diagnosis: Is Parathyroid Transplantation Indicated? , 1996, World Journal of Surgery.
[174] J. Church,et al. Risk of Rectal Cancer in Patients After Colectomy and Ileorectal Anastomosis for Familial Adenomatous Polyposis , 2003, Diseases of the colon and rectum.
[175] P. Goodfellow,et al. Increased Risk for Hereditary Nonpolyposis Colorectal Cancer-Associated Synchronous and Metachronous Malignancies in Patients with Microsatellite Instability-Positive Endometrial Carcinoma Lacking MLH1 Promoter Methylation , 2004, Clinical Cancer Research.
[176] K. Neale,et al. Desmoid tumours complicating familial adenomatous polyposis , 1999, The British journal of surgery.
[177] J. Potter,et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.
[178] J. Moley,et al. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. , 1999, Annals of surgery.
[179] L. Aaltonen,et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. , 1993, Cancer research.
[180] J. Farndon,et al. The Importance of Early Diagnosis in Patients with Hereditary Medullary Thyroid Carcinoma , 1982, Annals of surgery.
[181] M. Munsell,et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. , 2006, The New England journal of medicine.
[182] R. Tollenaar,et al. MRI screening for breast cancer in women with high familial and genetic risk: First results of the Dutch MRI screening study (MRISC). , 2003 .
[183] H. Meijers-Heijboer,et al. Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer , 2004, Clinical Cancer Research.
[184] S. Piantadosi,et al. Primary chemoprevention of familial adenomatous polyposis with sulindac , 2002 .
[185] A. Neugut,et al. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[186] P. Balladur,et al. Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis , 1998, The British journal of surgery.
[187] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[188] W. Donegan,et al. Breast tumor incidence in rats after partial mammary resection. , 1983, Archives of surgery.
[189] J. Norton,et al. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. , 1993, Surgery.
[190] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[191] Jing Li,et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.
[192] K. Schmid,et al. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment , 1995, Diseases of the colon and rectum.
[193] H. Lynch,et al. Lynch syndrome: genetics, natural history, genetic counseling, and prevention. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[194] B. Ponder,et al. Mutations of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.
[195] H. Anton-Culver,et al. Hormone replacement therapy in breast cancer survivors: a cohort study. , 1996, American journal of obstetrics and gynecology.
[196] M. Wallace,et al. Upper gastrointestinal disease in patients with familial adenomatous polyposis , 1998, The British journal of surgery.
[197] Shannon K. McDonnell,et al. EFFICACY OF BILATERAL PROPHYLACTIC MASTECTOMY IN WOMEN WITH A FAMILY HISTORY OF BREAST CANCER , 1999 .
[198] J. Klijn,et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[199] K. Kinzler,et al. Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.
[200] J. Church,et al. Prospective, Age-Related Analysis of Surgical Results, Functional Outcome, and Quality of Life After Ileal Pouch-Anal Anastomosis , 2003, Annals of surgery.
[201] A. Spigelman,et al. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study , 2002, Gut.
[202] S. Seal,et al. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[203] K. Offit,et al. Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations , 2001, Genetics in Medicine.
[204] S. Miller,et al. Effectiveness of prophylactic mastectomy in the prevention of breast tumors in C3H mice. , 1987, Plastic and reconstructive surgery.
[205] B. Rosen,et al. Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status , 2001, The American journal of surgical pathology.
[206] P. Butow,et al. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. , 1999, Gynecologic oncology.
[207] Rochelle L. Garcia,et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. , 2001, Gynecologic oncology.
[208] J. Church,et al. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. , 1998, Annals of surgery.
[209] C. Scaife,et al. Lynch syndrome: implications for the surgeon. , 2003, Clinical colorectal cancer.
[210] J. Kleibeuker,et al. Surveillance for Hereditary Nonpolyposis Colorectal Cancer: A Long-Term Study on 114 Families , 2002, Diseases of the colon and rectum.
[211] B. Ponder,et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.
[212] Z. Cohen,et al. Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors , 2001, Diseases of the colon and rectum.
[213] J. Church,et al. Staging Intra-Abdominal Desmoid Tumors in Familial Adenomatous Polyposis: A Search for a Uniform Approach to a Troubling Disease , 2005, Diseases of the colon and rectum.
[214] M. Nelen,et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. , 1997, Human molecular genetics.
[215] A. Pinchera,et al. Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. , 1995, Surgery.
[216] G. Kenter,et al. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer , 2002, International journal of cancer.
[217] T. Lairmore,et al. Hereditary endocrinopathies. , 1999, Current problems in surgery.
[218] Ailsa E Gebbie,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333 , 2002, Journal of Family Planning and Reproductive Health Care.